| Literature DB >> 27842772 |
Lawrence A Vernetti1, Andreas Vogt2, Albert Gough2, D Lansing Taylor3.
Abstract
In this article, we review the past applications of in vitro models in identifying human hepatotoxins and then focus on the use of multiscale experimental models in drug development, including the use of zebrafish and human cell-based, 3-dimensional, microfluidic systems of liver functions as key components in applying Quantitative Systems Pharmacology (QSP). We have implemented QSP as a platform to improve the rate of success in the process of drug discovery and development of therapeutics.Entities:
Keywords: Drug discovery; Drug-induced liver injury; Human liver models; In vitro hepatotoxicity; Liver toxicology; Microphysiology liver; Quantitative system pharmacology
Mesh:
Year: 2017 PMID: 27842772 PMCID: PMC6325638 DOI: 10.1016/j.cld.2016.08.013
Source DB: PubMed Journal: Clin Liver Dis ISSN: 1089-3261 Impact factor: 6.126